Title Solobacterium moorei 敗血症の 1 例 : 本邦初の特徴について ( 本文 (Fulltext) ) Author(s) 森, 早苗 Citation [ 日本臨床微生物学雑誌 = The journal of the for Clinical Microbiolog
|
|
|
- みそら こびき
- 4 years ago
- Views:
Transcription
1 Title Solobacterium moorei 敗血症の 1 例 : 本邦初の特徴について ( 本文 (Fulltext) ) Author(s) 森, 早苗 Citation [ 日本臨床微生物学雑誌 = The journal of the for Clinical Microbiology] vol.[1 Issue Date Rights The Japanese Society for Clinical 物学会 ) Version 出版社版 (publisher version) postprin URL この資料の著作権は 各資料の著者 学協会 出版社等に帰属します
2 Solobacterium moorei 1 1) 1) 1) 1) 1) 1) 2) 1) 2) Solobacterium moorei Prevotella melaninogenica RapID ANAII, API 20A Eggerthella lenta E. lenta 16S rrna Solobacterium moorei 99.6 S. moorei E. lenta a-glucosidase E. lenta S. moorei Key words: Solobacterium moorei 16S rrna, Eggerthella lenta Solobacterium moorei 2000 Kageyama 1) S. moorei Solobacterium 1) 2), 3) S. moorei 3 4 6) S. moorei ( ) TEL: FAX: t watari@kitami.jrc.or.jp mmhg 44 mmhg 75/ 1 WBC /ml CRP mg/dl Vol. 18 No
3 Solobacterium moorei Peripheral blood Blood chemistry RBC /ml TP 5.8 g/dl Hb 10.3 g/dl AST 59 IU/L Ht 29.2 ALT 55 IU/L LD 160 IU/L WBC /ml Total-Bill 0.3 mg/dl Seg 83.4 UN 22.6 mg/dl Lym 8.4 Cr 0.8 mg/dl Mono 3.0 Na 130 meq/l Eosino 2.7 K 3.8 meq/l Baso 0.7 Cl 87 meq/l Plt /ml CRP mg/dl pazufloxacin 1,000 mg/day 7 micafungin 50 mg/day 16 7 cefozopran 1 g/day 7 14 cefpirome 1 g/ day CRP 9 23 mg/dl F 93F BD BACTEC 9120 BD ) BACTEC F Bartholomew & Mittwer M 2) 2 93F II 5 TSA BD BY BYCHO BD BTB BTB BD ABHK ABHK NV ABHK NVABHK BBE BBE BD TSA BYCHO 35 7 CO 2 BTB 35 ABHK NVABHK 35 3) ABHK RID Zyme IND-S RapID ANAII API 20 A CRYSTAL ANR BD 16S rrna RapID ANAII 4) MIC MIC 5) S. moorei Eggerthella lenta ATCC RapID ANAII API 20A 1 E. lenta ATCC43055 S. moorei ABHK 48 Bartholomew & Mittwer RapID ANAII API 20A CRYSTAL ANR E. lenta Vol. 18 No
4 238 1 Bartholomew & Mittwer 1, ) 1 2) TSA BYCHO BTB 48 2 ABHK 1mm 2 ABHK NVABHK BBE 2 3) RapID ANAII , 91.3 Eggerthella lenta (Wade et al., 1999) 7) API20A E. lenta , 94.2 CRYSTAL ANR Atopobium minutum Solobacterium moorei 48 ABHK 78.9 CRYSTAL ANR RapID ANAII API 20A E. lenta E. lenta 16S rrna S. moorei (JCM T ) Vol. 18 No
5 Solobacterium moorei Solobacterium moorei Antimicrobial agent MIC (mg/ml) Ampicillin 0.06 Penicillin G 0.06 Piperacillin 0.5 Cefmetazole 0.5 Ceftizoxime 0.5 Cefozopran 0.5 Flomoxef 0.5 Imipenem 0.12 Amoxicillin/clavalanic acid 0.18 Clindamycin 0.06 Minocycline 0.12 Chloramphenicol 4 Sparfloxacin 0.25 S. moorei BBE Prevotella melaninogenica RapID ANAII P. melaninogenica ) S. moorei 2 MIC chloramphenicol 4 mg/ml sparfloxacin 0.25 mg/ml MIC cefozopran MIC 0.5 mg/ml P. melaninogenica sparfloxacin 2 mg/ml 5) S. moorei Eggerthella lenta ATCC E. lenta S. moorei 3 RapID ANAII S. moorei arginine, serine a-glucosidase E. lenta arginine serine a-glucosidase RapID ANAII E. lenta ATCC 1), 6), 8) S. moorei 3 API 20A S. moorei E. lenta E. lenta ATCC E. lenta CRYSTAL ANR S. moorei E. lenta ATCC arginine, serine, glycine, ala- 3 Solobacterium moorei (A) Eggerthella lenta ATCC43055 (B) S. moorei E. lenta Bartholomew & Mittwer 1,000 Vol. 18 No
6 240 3 Eggerthella lenta ATCC43055 RapID ANAII Biochemical reaction or enzyme Isolate Results E. lenta ATCC43055 Published S. moorei strain a Urease p-nitrophenyl-b,9-disaccharide (b-disaccharidase) NT p-nitrophenyl-a,a-arabinoside (a-arabinosidase) o-nitrophenyl-b,9-galactoside (b-galactosidase) p-nitrophenyl-a,9-glucoside (a-glucosidase) p-nitrophenyl-b,9-glucoside (b-glucosidase) p-nitrophenyl-a,9-galactoside (a-galactosidase) p-nitrophenyl-a,a-fucoside (a-fucosidase) p-nitrophenyl-n-acetyl-b,9-glucosaminide (N-Acetyl-glucosaminidase) p-nitrophenylphosphate NT Leucyl-glycine-b-naphthylamide NT Glicine-b-naphthylamide NT Proline-b-naphthylamide (Proline arylamidase) Phenylalanine-b-naphthylamide NT Argnine-b-naphthylamide (Arginine dehydrogenase) Serine-b-naphthylamide NT Pyrrolidonyl-b-naphtylamide NT Indole production Nitrate reduction Catalase a NT: not tested nine, pyroglutamic acid, lysine, methionine, phenylalanine, leucine 2 E. lenta 2 3 Eubacterium E. lenta 9) E. lenta 10) chloramphenicol sparfloxacin MIC MIC E. lenta E. lenta Solobacterium moorei S. moorei S. moorei E. lenta API 20A CRYSTAL ANR E. lenta API 20A 20 Vol. 18 No
7 Solobacterium moorei RapID ANAII S. moorei a- glucosidase E. lenta a-glucosidase CRYSTAL ANR RapID ANAII CRYSTAL ANR S. moorei CRYS- TAL ANR S. moorei RapID ANAII a-glucosidase Eubacterium 11) ) ) S. moorei S. moorei 3 S. moorei S rrna S. moorei E. lenta S. moorei Vol. 18 No
8 Vol. 18 No Solobacterium moorei Underlying Author Country Age Sex Year Portal of entry disease Infection type Identification Treatment Outcome copathogens Present study Japan 60 male 2008 Larynx cancer Abscessus of cervix Mixed P. melaninogenica Detry, G., et al. Anaerobe 12: Susanna, K. P. Lau, et al. JCM 44: Claire A. Martin, et al. JMCR1: 40 Belgium 67 male 2006 Multiple myeloma Abscessus of root portion of the tooth Hong Kong 43 female 2006 Cervix cancer Acute proctitis a England (UK) 37 male 2007 Intravenous drug user (mucosa) Abscessus of injection insertion site Mixed Oral flora Mixed Unclear Mixed Bacteroides sp. Fusobacterium sp. 16S rrna gene PZFX CZOP Death 16S rrna gene CFPM AMK Cure 16S rrna gene PIPC/TAZ ND 16S rrna gene Metronidazole PCG Cure a by radiation therapy; ND: no data; PZFX: pazufloxacin; CZOP: cefozopran; CFPM: cefepime; AMK: amikacin; PIPC/TAZ: piperacillin/tazobactam; PCG: benzylpenicillin
9 Solobacterium moorei ) Kageyama, A., Y. Benno Phylogenetic and phenotypic characterization of some Eubacterium-like isolates from human feces: Description of Solobacterium moorei gen. nov., sp. nov. Microbiol. Immunol. 44: ) Kazor, C. E., P. M. Mitchell, A. M. Lee, et al Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J. Clin. Microbiol. 41: ) Haraszthy, V. I., J. J. Zambon, P. K. Sreenivasan, et al Identification of oral bacterial species associated with halitosis. J. Am. Dent. Assoc. 138(8): ) Detry, G., D. Pierard, K. Vandoorslaer, et al Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe 12: ) Susanna, K. P. Lau, J. L. Teng, K. W. Leung, et al Bacteremia caused by Solobacterium moorei in a patientwith acute proctitis and carcinoma of the cervix. J. Clin. Microbiol. 44: ) Claire, A. Martin, Rohan S. Wijesurendra, Colin D. R. Borland, et al Femoral vein thrombophlebitis and septic pulmonary embolism due to a mixed anaerobic infection including Solobacterium moorei: A case report. J. Med., Case Reports 1: 40. 7) Wade, W. G., J. Downes, D. Dymock, et al The family Coriobacteriaceae: reclassification of Eubacterium exiguum (Poco et al., 1996) and Peptostreptococcus heliotrinreducens (Lanigan, 1976) as Slackia exigua gen. nov., comb. nov. and Slackia heliotrinireducens gen. nov., comb. nov., and Eubacterium lentum (Prevot 1938) as Eggerthella lenta gen. nov., comb. nov. IJSB 49: ) Eija Könönen, William G. Wade Propionibacterium, Lactobacillus, Actinomyces, and Other Non-Spore-Forming Anaerobic Gram- Positive Rods. p , In: Manual of Clinical Microbiology, 9 th ed. (P. R. Murray, E. J. Baron, M. A. Pfaller, et al. ed.), American Society for Microbiology, Washington, D.C. 9) Adriana Mosca, Paula Summanen, Sydney M. Finegold, et al Cellular Fatty Acid Composition, Soluble-Protein Profile, and Antimicrobial Resistance Pattern of Eubacterium lentum. J.Clin. Microbiol. 36: ) (5) p ) Bernard J. Moncla, Sharon L. Hillier Peptostreptococcus, Propionibacterium, Lactobacillus, Actinomyces, and Other Non-Spore- Forming Anaerobic Gram-Positive Bacteria. p , In: Manual of Clinical Microbiology, 8 th ed. (P. R. Murray, E. J. Baron, M. A. Pfaller, et al. ed.), American Society for Microbiology, Washington, D.C. 12) : ) p Vol. 18 No
10 244 Solobacterium moorei as a Cause of Sepsis in a Patient with Larynx Cancer: A First Case Report in Japan and Characterization of the Isolate Sanae Mori, 1) Tomohisa Watari, 1) Atushi Yasuda, 1) Sachiko Miura, 1) Takashi Ogaya, 1) Munehiro Hatanaka, 1) Kiyofumi Ohkusu 2) 1) Department of Clinical Laboratory, Kitami Red Cross Hospital 2) Department of Microbiology, Gifu University Graduate School of Medicine Herein we report the first Japanese case of sepsis caused by Solobacterium moorei, an anaerobic, non-sporulated Gram-positive bacillus in a patient with terminal-stage laryngeal cancer. A 60-year-old male was admitted to our hospital with high fever and fatigue. He had a long-lasting medical history and had a subcutaneous neck abscess. A set of blood culture was obtained with the BACTEC Aerobic/92F and Anaerobic/93F resin bottles. After 2 days, Gram-variable polymorphic rods and Prevotella melaninogenica grew from only the anaerobic culture vial. The RapID ANA system indicated that the Gram-variable polymorphic rod was 91.3 likely to be Eggerthella lenta. The API 20A system also showed that it was 94.2 likely to be E. lenta. However, we hesitated to identify it as E. lenta due to the discrepancies between results of our biochemical tests and of those reported in the literature. We therefore performed PCR amplification and DNA sequencing of the 16S rrna gene of the isolate. A sequence of 1450 bp was found to be 99.6 homologous to the S. moorei type strain sequence (AY044915), indicating that the isolate was a strain of S. moorei, note. lenta. Tofurther characterize the isolate, we compared it with E. lenta strain (ATCC43055). It was found that they share the same phenotypical characteristics, except the isolate was negative for the catalase and the nitrate reduction tests, and positive for the a-glucosidase test. Thus, it is likely that S. moorei and E. lenta would be di#erentiated by these three reactions in clinical microbiology laboratory. 24 Vol. 18 No
CHEMOTHERAPY APRIL 1992 Table 2. Concentration of meropenem in human prostatic fluid Table 1. Background of 21 chronic complicated UTI cases * NB + BPH, NB + Kidney tumor, NB + Kidney tuberculosis Table
Key words : R-plasmid, Urinary tract infection, E. coli Fig. 1. MIC distribution against E. coli isolated from urinary tract (366 strains) and isolation - frequencies of drug-resistant strains Table 1.
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
Fig. 1 Chemical structure of DL-8280
Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.
28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90
2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low
CHEMOTHERAPY
CHEMOTHERAPY VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin CHEMOTHERAPY AUG. 1993 VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin Table 1. Comparative in vitro activity of teicoplanin
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile
Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile Key words: temafloxacin, TA-167, Bacteroides fragilis,
Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone
Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone (inoculum size= 106 CFU/ml) (Ĉ-lactamase producer : 2 strains) Fig. 1. Sensitivity distribution of
Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection
Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin
VOL. 43 NO. 4
VOL. 43 NO. 4 Fig. 1. Frequency of Enterococcus species from complicated UTI, 1988-1992. the number * of Enterococcus species/the number of cases with complicated UTI. Fig. 3 Epidemiologic characteristics
Title 文化と解釈 (2) : 昭和思想史試論 Author(s) 津田, 雅夫 Citation [ 岐阜大学教養部研究報告 ] no.[31] p.[1]-[14] Issue Date 1995-02 Rights Version 岐阜大学教養部倫理学教室 (The Faculty of Gene Gifu University) URL http://repository.lib.gifu-u.ac.j
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
2) Goetz, A., Tsuneishi, N.: Application of molecular filter membranes to the bacteriological analysis of water, J. Am. Water Works Assn., 43 (12): 943-969,1951. 3) Clark, H.F. et al.: The membrane filter
日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
Table 1.Quality control of MICs for reference strains Table 2.Antimicrobial activity of gatifloxacin against aerobic bacteria Table 4.Antimicrobial activity of gatifloxacin and other quinolones against
明海大学歯学雑誌 ３７‐２／１．秦泉寺
J Meikai Dent Med 37, 153 158, 8 153 1 7 5ml /1 min Wong-Baker Face Rating Scale FS 5 1 9. g 3 5ml /1 min, FS 1 66 6ml /1 min FS 5 1 9. g 3 6ml /1 min, FS 3 Two Cases of Xerostomia that Showed an Improvement
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent
Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Enterococcus faecalis Klebsiella pneumoniae, Morganella
1) Kojima H: Culture of ejaculate for Neisseria gonorrhoeae, 1st Serually Transmitted Diseases World Congress, San Juan, 11. 19, 1981. 9) Kojima H, Mori C: Clinical studies on Conococcal and Chlamydial
Title 独裁者 の英音法 : 文章構造とリズム構造 Author(s) 寺島, 隆吉 Citation [ 岐阜大学教養部研究報告 ] vol.[25] p.[303]-[ Issue Date 1989 Rights Version 岐阜大学教養部英語研究室 (Faculty of General Gifu University) URL http://repository.lib.gifu-u.ac.j
日本化学療法学会雑誌第53巻第S-3号
moxifloxacin in vitro moxifloxacin in vitro 17 9 6 17 11 21 moxifloxacinmflx in vitro cefdinir CFDNclavulanic acidamoxicillincvaampcclarithromycincamclindamycincldm levofloxacinlvfx 1MFLX Clostridium clostridiiformeclostridium
400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote
aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Proteus mirabilis 3.13, Proteus vulgaris 1.56, Citrobacter freundii 0.39,
VOL.42 S-1
CHEMOTHERAPY APR. 1994 VOL.42 S-1 CHEMOTHERAPY APR. 1994 Table 1. Criteria for evaluation of clinical efficacy by the Japanese Society of Oral and Maxillo-Facial Surgeons Grades of symptoms and numerical
Title ジョイスと < 都市 > ( その 1) : < 麻痺 > の意味するもの Author(s) 伊藤, 徳一郎 Citation [ 岐阜大学教養部研究報告 ] vol.[18] p.[125]-[ Issue Date 1982 Rights Version 岐阜大学教養部 (Faculty of General Educa URL http://repository.lib.gifu-u.ac.j
CHEMOTHERAPY APRIL 1992 VOL. 40 S- 1 Table 1-1. Comparative in vitro activity of meropenem against clinical isolates CNS: coagulase-negative staphylococci CHEMOTHERAPY APRIL 1992 Table 1-2. Comparative
Title 井伏鱒二著作年表稿 ( 昭和 16 年 ~20 年 ) Author(s) 前田, 貞昭 Citation [ 岐阜大学教養部研究報告 ] vol.[21] p.[47]-[9 Issue Date 1985 Rights Version 岐阜大学教養部文学研究室 (Faculty of General Gifu University) URL http://repository.lib.gifu-u.ac.j
Table 1 Antibacterial spectra of CPM and other antimicrobials against anaerobes Fig. 1 In vitro activity of CPM and other antibiotics against B. fragilis (136 strains) Fig. 2 In vitro activity of CPM and
1272 CHEMOTHERAPY MAR. 1975
1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides
Table1MIC of BAY o 9867 against standard strains
Table1MIC of BAY o 9867 against standard strains Fig.2Cumulative and Distribution Curves of MIC (S.aureus 54 strains) 106cfu/ml Fig.3Correlogram of MIC (S.aureus 54 strains) CHEMOTHERAPY 451 Fig.4Cumulative
CHEMOTHERAPY JUNE 1986
VOL. 34 S-3 CHEMOTHERAPY Fig. 1 Structural formula of L-105 CHEMOTHERAPY JUNE 1986 VOL. 34 S-3 CHEMOTHERAPY Table 1 Antibacterial spectra of L-105 against gram negative anaerobic rods Inoculum 106 cells/ml
VOL. 34 S-2 CHEMOTH8RAPY 913
VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(
1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
988 CHEMOTHERAPY NOV. 1971
988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical
VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against
_02三浦.indd
36, 7-11, 2016 IPD PCV 5 3 80% 1 invasive pneumococcal disease ; IPD 2010 7 PCV7 2013 13 PCV13 IPD IPD 2,3 2015 1 2015 12 5 1 IPD 2015 1 12 IPD 5 IPD 1 4 2 5 http://pneumocatch.jp/ 5 Statens Serum Institut
Title 森田草平 煤煙 と 自叙伝 Author(s) 根岸, 正純 Citation [ 岐阜大学教養部研究報告 ] vol.[6] p.[101]-[1 Issue Date 1970 Rights Version 岐阜大学教養部 (Faculty of General Educa URL http://repository.lib.gifu-u.ac.j この資料の著作権は 各資料の著者
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
Table 1.Resistance criteria Fig.1.The resistance rates of piperacillin,ceftazidime, cefsulodin,imipenem,aztreonam,gentamicin,tobramycin,amikacin,isepamicin,fosfomycin and ofloxacin against 2,793 strains
Some Investigations of Urinary Candidiasis Chujiro YAMAMOTO, M. D., Mitsushi MIZUTANI, M. D. and Tokuro SATO, M. D. From the Department of Urology, Ni
Title 尿路 Candida 症に於ける 2,3 の検索 Author(s) 山本, 忠治郎 ; 水谷, 三 ; 佐藤, 徳郎 Citation 泌尿器科紀要 (1961), 7(3): 394-405 Issue Date 1961-03 URL http://hdl.handle.net/2433/112109 Right Type Departmental Bulletin Paper Textversion
CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection
無水エタノールによる硬化療法および鼻粘膜癒着処置を施行したオスラー病による難治性鼻出血の１例
119 874 2016 : 0 1cc : : : : : :WBC3 640/μl RBC 247 10 /μl PLT 22 9 10 /μl Hb 7 9g/dl PT APTT : : : 1ml 30G absolute ethanol Et 0 1 0 2ml 2mm 119 875 1 000mg/day Et 0 3ml Al Deen endoglin ALK1 1 3 a b
CHEMOTHERAPY DEC Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus, G; Gaffk
VOL. 30 S-3 CHEMOTHERAPY imeumoniae, Serratia marcescens, Proteus sp, CHEMOTHERAPY DEC. 1982 Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus,
Key words: Antibodies to Leptospira, Tokyo, Uveitis
Key words: Antibodies to Leptospira, Tokyo, Uveitis Fig. 1 Distribution of Antibody Titers in Age Decade Fig. 3 Distribution of Antibody Titers in each Strain Fig. 2 Correlation between Antibody Titers
DISTRIBUTION OF NEUROPEPTIDES IN THE INFERIOR NASAL TURBINATE MUCOSA OF PATIENTS WITH ALLERGIC RHINITIS KAZUHIRO YAMAMOTO. M.D. Department of Otolaryngology, School of Medicine, Kitasato University, Sagamihara
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,
CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates
VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak
名称未設定-1
Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA
Rinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
sick contact1l
Clinical Question 2017 年 5 月 15 日 分野 : 内分泌テーマ : 治療 19 14 15 18 sick contact1l 170cm/68.8kg, GCSE1V1M5, HR: 120/min, BP: 104/60mmHg, RR: 30/min, SpO 2 : 96%, BT: 38.0 WBC Hb PLT CRP Cr BUN 23400 15.0 35.5
1) Michaelis L. Biochem Z., 59, 78, 1914. 2) Ferris H. C. Dent. Cosmos Phila., 63, 10, 93, 1921. 3) Bloomfield A. L. Bull Johns Hopk. Hosp. Bait., 31, 118, 1920. 4) Starr H. C. J. Biol. Chem. Bait., 54,
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the
CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin
CHEMOTHERAPY CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY Fig. 1 MICs of sultamicillin against respiratory pathogenic Branhamella catarrhalis 62 strains, inoculum size 106CFU/m1 Fig.
Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL
Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): 278-291 Issue Date 1965-04 URL http://hdl.handle.net/2433/112732 Right Type Departmental Bulletin Paper
Fig.1 MICs of penicillins against 24 strains of B. pertussis Fig.2 MICs of cepherns against 24 strains of B. pertussis Fig.3 MICs of macrolides against 24 strains of B. pertussis Fig.4 MICs of nalidixic
indd
60 4 2010 197 症例報告 1 1 1 2 2 2 2 3 4 1 2 3 4 2010 7 27 2010 9 24 Case of a Young Adult Male Complicated with Ischemic Colitis EMI OGATA 1, TAKERU WAKATSUKI 1, HIROAKI SAKAMOTO 1, NATSUMI SAKAMOTO 2, OSAMU
indd
18 61 1 2011 症例報告 2010 5 13 2010 12 20 A Case of Varicella with Severe Back Pain in a Patient with Systemic Lupus Erythematosus RIE SAITO, KIORI YANO, FUMIKO KATSUSHIMA, HARUYO IWADATE, HIROKO KOBAYASHI,
) Meropenem Chemotherapy (Tokyo) ) panipenem/betamipron Chemotherapy (Tokyo) ) Meropenem Chemotherapy (Toky
2.7 2.7.5 1) 199846410-437 2) UTI ( )UTI ( 3 )Chemotherapy (Tokyo) 1986 34408-441 3) () 199745762-778 4) 1992 5) 199543 6) Chemotherapy (Tokyo) 199139687-689 7) Imipenem/Cilastatin sodium (MK-0787/MK-0791)
Table 1 Sensitivity distribution of clinical isolates 1. Escherichia coli Inoculum size: 106cells/ml 2. Klebsiella pneumoniae 3. Enterobacter cloacae 4. Serratia marcescens Inoculum size: 106cells/nil
VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St
CHEMOTHERAPY VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant Staphylococcus aureus CHEMOTHERAPY Table
2012 Vol. 23 No pseudothrombophlebitis pseudothrombophlebitis
pseudothrombophlebitis 5 424 163 38.1 26 6.1 5 1.2 230 2 3 66.4 51 80 2 3 2 2 1 2012 23 3 261-265 pseudothrombophlebitis 1 2011 7 11 30 2010 2 5 47 Fig. 1 Ultrasonography showed a low echoic cyst in the
:. * ** *** **** Little Lord Fauntleroy Little Lord Fauntleroy Frances Eliza Hodgson Burnett, - The Differences between the Initial Edition and First
Title 若 松 賤 子 訳 小 公 子 の 初 出 本 文 と 初 版 本 文 の 異 同 につ いて( fulltext ) Author(s) 北 澤, 尚 ; 趙, 燦 Citation 東 京 学 芸 大 学 紀 要. 人 文 社 会 科 学 系. I, 60: 93-160 Issue Date 2009-01-30 URL http://hdl.handle.net/2309/96196
Key words:group D streptococci,classification,enterococcal infections, Antibiotic susceptibility,vancomycin
Key words:group D streptococci,classification,enterococcal infections, Antibiotic susceptibility,vancomycin Table 1 Differentiation of group D streptococcia aderived from R.R.Facklam1,2),K.C.Gross-et al3),and
顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎２症例
11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO
Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H.
Key words: Campylobacter fetus,meningitis Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H. 273 昭 和61年3月20日 Table 2 Case 2.T.N. Fig.3 Case2,T.N.Clinical Campylobacter Fig.2
Genus Corynebacteria Non-lipophilic The nonlipophilic bacteria may be classified as fermentative and non-fermentative: Fermentative Corynebacteria Cor
Corynebacterium kroppenstedtii Genus Corynebacteria Non-lipophilic The nonlipophilic bacteria may be classified as fermentative and non-fermentative: Fermentative Corynebacteria Corynebacterium diphtheriae
Title 舟橋聖一 白い魔魚 論 : ビルドゥングスロマン / 中間小説 / 風土小説 Author(s) 林, 正子 Citation [ 岐阜大学国語国文学 ] no.[34] p.[1]-[23] Issue Date Jan-08 Rights Version URL http://repository.lib.gifu-u.ac.j この資料の著作権は 各資料の著者 学協会 出版社等に帰属します
Table 1 Survival rates of infected mice given antibiotic doses producing peak serum a) S. aurcus Smith Challenge dose :7 ~10 (5% mucin) CFU/mouse. LD50: 1 ~103 (5% mucin) CFU/mouse. Table 2 Survival rates
Table 1 Characteristics of the study participants in Imari municipal hospital
Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin
1) i) Barber, M. et al.: Brit. Med J, 2, 565, 19'49. ii) Barber, M.F.G. J. Hayhoe and J. E. M. Whithead: Lancet, 1120 `1125, 1949.-2) Bergey: Bergey's Manual of Determinative Bacteriology 7 th Ed: (1958).-3)
epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia
epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia Table 3. Overall clinical efficacy of cefozopran in
2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun
10 1-14 2014 1 2 3 4 2 1 2 3 4 Web PubMed elbow pain baseball elbow little leaguer s elbow acupuncture electric acupuncture 2003 2012 10 39 32 Web PubMed Key words growth stage elbow pain baseball elbow
b) Gram-negative bacteria Fig. 2 Sensitivity distribution of clinical isolates : E. coli Fig. 3 Sensitivity distribution of clinical isolates : Pseudomonas Fig. 1 Sensitivity distribution of clinical isolates
Table 1. Antimicrobial drugs using for MIC
Table 1. Antimicrobial drugs using for MIC Table 2. Susceptibilities determined with the VITEK 2 system and agar dilution reference by interpretive eategory for Staphylococcus aureus Table 3. Interpretive
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity CHEMOTHERAPY MAR. 1989 Mble 1. Allcrgy in parients nduced by penams VOL. 37 NO. 3 Table 2. Allergy in patients induced by
Continuous Cooling Transformation Diagrams for Welding of Mn-Si Type 2H Steels. Harujiro Sekiguchi and Michio Inagaki Synopsis: The authors performed
Continuous Cooling Transformation Diagrams for Welding of Mn-Si Type 2H Steels. Harujiro Sekiguchi and Michio Inagaki Synopsis: The authors performed a series of researches on continuous cooling transformation
Title 人 生 の 意 味 への 問 いの 諸 相 : 問 いのきっかけや 重 要 性, 自 我 体 験 との 関 連 から Author(s) 浦 田, 悠 Citation 京 都 大 学 大 学 院 教 育 学 研 究 科 紀 要 (2008), 54: 112-124 Issue Date 2008-03-31 URL http://hdl.handle.net/2433/57035 Right
SARS HIV/AIDS n = 672; % 5% 2% 8% 16% 43% 20%
SARS HIV/AIDS n = 672; 20074 20108 6% 5% 2% 8% 16% 43% 20% 1999 2008 HIV/AIDS B A 0% 50% 100% 1049 552 17 186 867 431 739 3847 332 7556 102 2420 3648 449 802 2709 31774 1286 13651 1611 207 95 8 162 667
SURE: Shizuoka University REp http://ir.lib.shizuoka.ac.jp/ Title Emersonの'The American Scholar'について Author(s) 重 松, 宗 育 Citation 人 文 論 集. 26, p. A59-A77 Issue Date 1975-12-25 URL http://doi.org/10.14945/00008654
Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL
Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date 1958-01 URL http://hdl.handle.net/2433/111559 Right Type Departmental Bulletin
Title 生活年令による学級の等質化に関する研究 (1) - 生活年令と学業成績について - Author(s) 与那嶺, 松助 ; 東江, 康治 Citation 研究集録 (5): 33-47 Issue Date 1961-12 URL http://hdl.handle.net/20.500.12000/ Rights 46 STUDIES ON HOMOGENEOUS
硫酸アルミニウムカリウムタンニン酸注射液（ALTA）による内痔核硬化療法後にフルニエ症候群をきたした1例 第65巻02号0075頁
65 V A Case Report of Fournier s Gangrene after Sclerosing Therapy for Internal Hemorrhoids with Aluminum Potassium Sulfate and Tannic Acid (ALTA) Injection Aluminum potassium sulfate and tannic acid
VOL.48 NO.7 lase negative staphylococci, Escherichia coli, Klebsiella spp., Citrobacter freundii, Enterobacter spp., indole-positive Proteus, Serratia
ceftazidime, cefpirome, cefepime, cefoperazone/sulbactam (2: 1), imipenem Staphylococcus aureus oxacillin coagulase negative staphylococci Escherichia coli piperacillin Klebsiellac spp. Citrobacter Pseudomonas
VOL.39 S-3
VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose
Vol.60 No.3 December JACAR Ref. A - -
Title 明治期の大阪高等工業学校 Author(s) 沢井, 実 Citation 大阪大学経済学. 60(3) P.1-P.21 Issue 2010-12 Date Text Version publisher URL http://doi.org/10.18910/51033 DOI 10.18910/51033 Rights Osaka University Vol.60 No.3 December
32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ
29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27
日本化学療法学会雑誌第59巻第6号
P P Streptococcus pneumoniae S. pneumoniae Key words Streptococcus pneumoniae Fig. 1. Capsular swelling reaction of S. pneumoniae type 6B. Cells are stained dark blue using a methylene blue. Capsule is
Key words: Leukemia, Bacillus cereus, Septicemia
Key words: Leukemia, cereus, Septicemia Table 1 Common examination, hemogram and pattern serum electrophoresis, after admission Table 2 Myelogram patient, before antileukemic chemorapy (Sternum, July 13)
日赤 Ｎｏ．３５☆／７．河相
2 64 2 Mucosa-Associated Lymphoid TissueMALT T γ- 1 Key words T 1 2 64 47 54 60 MALT 63 T MALT 6062-8 63 1 T MALT 63 CHOP 2 35 28 30 28 75 μg 200 mg 20 mg 200 mg 400 mg/80 mg 2 35 mg 1 2 150 mg 200 mg
Title 体 験 話 法 の 機 能 について : 二 重 の 視 点 性 の 観 点 から Author(s) 三 瓶, 裕 文 Citation (37): 17-32 Issue 2012-05 Date Type Journal Article Text Version publisher URL http://hdl.handle.net/10086/25722 Right Hitotsubashi
Title ゲルニカ の 影 : 飛 行 機 と 誰 がために 鐘 は 鳴 る Author(s) 平 井, 智 子 Citation Osaka Literary Review. 40 P.77-P.88 Issue 2001-12-24 Date Text Version publisher URL http://hdl.handle.net/11094/25189 DOI Rights Osaka
Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad
Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution
Unknown
Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ
Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)
Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2305(45) 2306(46) THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 Dec. Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2307(47) 2308(48) THE JAPANESE
untitled
11-19 2012 1 2 3 30 2 Key words acupuncture insulated needle cervical sympathetick trunk thermography blood flow of the nasal skin Received September 12, 2011; Accepted November 1, 2011 I 1 2 1954 3 564-0034
CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus
VOL. 32 S-4 CHEMOTHERAPY Fig. 1 Chemical structure of sodium cefoperazone Fig. 2 Chemical structure of sodium cefoperazone CHEMOTHERAPY JUN. 1984 Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter
semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG
CLINICAL STUDIES OF UROGENITAL INFECTIONS WITH CHLAMYDIA TRACHOMA TIS Report 2. The Epidemiology of Chlamydial Infections in Okayama District in Japan and Detection of Antibodies to Chlamydiae in the Sera
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba
Hirosaki University Repository 妊 娠 可 能 てんかん 女 性 の 治 療 管 理 基 準 設 定 に 関 する 研 Title 究 Author(s) 兼 子, 直 Citation てんかん 治 療 研 究 振 興 財 団 研 究 年 報. 4, 1992, p.24-35 Issue Date 1992 URL http://hdl.handle.net/10129/1905